Search results

Search Web pagesPDFs

Results will auto-populate based on filter selection.

Filters
Forms
News Release
Operational Policy Manual
(-) Page
Keywords
FAQ
Forms
Provider profile
Found 626 result(s)
Drug formulary listing decision - Aripiprazole
Indication(s)The treatment of schizophrenia and related psychotic disorders, manic or mixed episodes in bipolar I disorder, and for use as an adjunct to antidepressants for…
Drug formulary listing decision – Benzodiazepines
Indication(s)Benzodiazepines are indicated in a treatment of a variety of disorders (depending on their pharmacokinetic profile and evidence), including anxiety disorder,…
Drug formulary listing decision – Botulinumtoxin-A
Onabotulinumtoxin-A, incobotulinumtoxin-A, abobotulinumtoxin-A  Indication(s)  OnabotulinumtoxinA (Botox®) is indicated for the treatment of blepharospasm/VII…
Drug formulary listing decision – Buprenorphine for opioid use disorder
Buprenorphine/naloxone (SL), buprenorphine subdermal implant and buprenorphine extended-release (ER) injection Indication(s) Buprenorphine/naloxone sublingual (SL) tablet (…
Drug formulary listing decision – Buprenorphine in treatment of chronic pain
Burpenorphine transdermal patch - butrans® and burprenorphine buccal soluble film belbuca®Indication(s)The management of pain severe enough to require daily, continuous, long…